Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms. Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living. LPI (LP Information)' newest research report, the “Novel Drug Delivery Systems Industry Forecast” looks at past sales and reviews total world Novel Drug Delivery Systems sales in 2022, providing a comprehensive analysis by region and market sector of projected Novel Drug Delivery Systems sales for 2023 through 2029. With Novel Drug Delivery Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Novel Drug Delivery Systems industry. This Insight Report provides a comprehensive analysis of the global Novel Drug Delivery Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Novel Drug Delivery Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Novel Drug Delivery Systems market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Novel Drug Delivery Systems and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Novel Drug Delivery Systems. The global Novel Drug Delivery Systems market size is projected to grow from US$ 23770 million in 2022 to US$ 26870 million in 2029; it is expected to grow at a CAGR of 1.8% from 2023 to 2029. Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent. In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc. This report presents a comprehensive overview, market shares, and growth opportunities of Novel Drug Delivery Systems market by product type, application, key players and key regions and countries. Market Segmentation: Segmentation by type Liposomes PEGylated Proteins & Polypeptides Polymer Nanoparticle Protein–drug Conjugates Others Segmentation by application Hospitals & Clinic Cancer Treatment Centers Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Amgen Teva Roche UCB (Union Chimique Belge) Celgene Merck Gilead Sciences Sanofi Pfizer Takeda Bausch&Lomb Samyang Biopharmaceuticals Johnson & Johnson TOLMAR Astellas AMAG Pharmaceuticals AbbVie Dr Reddy AstraZeneca Aspen Acrotech Biopharma TWi Pharmaceuticals
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Novel Drug Delivery Systems Market Size 2018-2029 2
